Table 2.
Characteristic | Bioprosthesis longevity, y |
P Value | ||
---|---|---|---|---|
[0–5.9] | [6–14.9] | [15–28] | ||
Sex, n (%) | 0.60 | |||
Women | 28 (12.4) | 171 (75.6) | 27 (12.0) | |
Men | 24 (9.3) | 200 (77.8) | 33 (12.8) | |
Age at first implantation, n (%) | 0.035 | |||
[7–29] | 13 (10.1) | 103 (80.5) | 12 (9.4) | |
[30–39] | 9 (8.9) | 80 (79.2) | 12 (11.9) | |
[40–49] | 13 (11.9) | 81 (73.4) | 15 (14.7) | |
[50–59] | 5 (5.4) | 72 (77.4) | 16 (17.2) | |
[60–82] | 11 (21.1) | 37 (71.1) | 4 (7.8) | |
Age at first implantation, n (%) | 0.003 | |||
[7–59] | 39 (9.1) | 336 (78.5) | 53 (12.4) | |
[60–82] | 12 (23.1) | 37 (71.2) | 3 (5.8) | |
Blood type, n (%) | 0.008 | |||
A | 9 (5.2) | 134 (77.5) | 30 (17.3) | |
B | 12 (16.0) | 53 (70.7) | 10 (13.7) | |
AB | 4 (14.8) | 23 (85.2) | 0 (0.0) | |
O | 26 (12.5) | 163 (78.4) | 19 (9.1) | |
Antigen A, n (%) | 0.008 | |||
Positive (A or AB) | 13 (6.5) | 157 (78.5) | 30 (15.0) | |
Negative (B or O) | 38 (13.4) | 216 (76.3) | 29 (10.2) | |
Antigen B, n (%) | 0.14 | |||
Positive (B or AB) | 16 (15.7) | 76 (74.5) | 10 (9.8) | |
Negative (A or O) | 35 (9.2) | 297 (78.0) | 49 (12.9) | |
Rhesus, n (%) | 0.73 | |||
Positive | 48 (11.1) | 329 (76.3) | 54 (12.6) | |
Negative | 3 (5.8) | 44 (84.6) | 5 (9.6) | |
Valve replaced,n(%) | 0.46 | |||
Mitral | 29 (10.3) | 226 (80.4) | 26 (9.3) | |
Aortic | 22 (11.6) | 138 (72.6) | 30 (15.8) | |
Tricuspid or pulmonary | 1 (8.3) | 10 (83.4) | 1 (8.3) | |
Number of valves replaced, n (%) | 0.001 | |||
1 | 31 (8.2) | 292 (77.6) | 53 (14.2) | |
2 or 3 | 20 (18.7) | 82 (76.6) | 5 (4.7) |